Evorel Sequi
Last Updated on eMC 23-Jun-2016 View document | Janssen-Cilag Ltd Contact details
Versions
- 23-Jun-2016 to Current
- 08-Apr-2015 to 23-Jun-2016
- 10-Feb-2015 to 08-Apr-2015
- 30-Apr-2013 to 10-Feb-2015
- 09-Mar-2012 to 30-Apr-2013
- 06-Jan-2012 to 09-Mar-2012
- 03-Jun-2009 to 06-Jan-2012
- 22-Jan-2009 to 03-Jun-2009
- 04-Dec-2008 to 14-Jan-2009
- 04-Jun-2008 to 04-Dec-2008
- 03-Nov-2006 to 04-Jun-2008
- 30-Oct-2006 to 03-Nov-2006
- 03-Mar-2006 to 30-Oct-2006
- 05-May-2005 to 03-Mar-2006
- 06-Apr-2004 to 05-May-2005
- 04-Oct-2001 to 06-Apr-2004
- 13-Jul-2000 to 04-Oct-2001
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 23-Jun-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 08-Apr-2015 and displayed until 23-Jun-2016
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 10-Feb-2015 and displayed until 08-Apr-2015
Reasons for adding or updating:
- Change to section 6 - date of revision
Updated on 30-Apr-2013 and displayed until 10-Feb-2015
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 6 - date of revision
Updated on 09-Mar-2012 and displayed until 30-Apr-2013
Reasons for adding or updating:
- Change to date of revision
- Change of contra-indications
Updated on 06-Jan-2012 and displayed until 09-Mar-2012
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Change to instructions about overdose
- Change to side-effects
Updated on 03-Jun-2009 and displayed until 06-Jan-2012
Reasons for adding or updating:
- Change to date of revision
- Change to drug interactions
Updated on 22-Jan-2009 and displayed until 03-Jun-2009
Reasons for adding or updating:
- Change to date of revision
- Change due to user-testing of patient information
Updated on 04-Dec-2008 and displayed until 14-Jan-2009
Reasons for adding or updating:
- Change to date of revision
- Change to drug interactions
- Change to date of revision
- Change to Marketing Authorisation Holder
Updated on 04-Jun-2008 and displayed until 04-Dec-2008
Reasons for adding or updating:
- Change to drug interactions
Updated on 03-Nov-2006 and displayed until 04-Jun-2008
Reasons for adding or updating:
- Change to date of revision
Updated on 30-Oct-2006 and displayed until 03-Nov-2006
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 03-Mar-2006 and displayed until 30-Oct-2006
Reasons for adding or updating:
- Change of trade or generic name
- Change to appearance of the medicine
- Change to, or new, use for medicine
- Change to storage instructions
- Change to drug interactions
- Change of contra-indications
- Change to warnings or special precautions for use
- Change to information about driving or using machinery
- Change to information about pregnancy or lactation
- Change to side-effects
- Change to instructions about overdose
- Change to date of revision
Updated on 05-May-2005 and displayed until 03-Mar-2006
Reasons for adding or updating:
- Change to Further Information section
- Change to date of revision
Updated on 06-Apr-2004 and displayed until 05-May-2005
Reasons for adding or updating:
- Change of manufacturer
- Change to Further Information section
- Change to date of revision
Updated on 04-Oct-2001 and displayed until 06-Apr-2004
Reasons for adding or updating:
- Update to PIL
Updated on 13-Jul-2000 and displayed until 04-Oct-2001
Reasons for adding or updating:
- No reasons supplied
Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
+44 (0)1494 567 568
+44 (0) 1494 567 445
+44 (0)1494 567 567
+44 (0)800 731 8450
+44 (0)800 731 5550
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue